Arif Nur Muhammad Ansori

Part - @Sato_Y_Lab, @KumamotoUniv_PR | Member - @EVirusBioinfC @AmerSocVirol @WSVirology | Researcher - @unair_official | Editor - @SciReports @FrontiersIn

[Humas Polda Jabar @humaspoldajbr]

KLARIFIKASI HOAX - MISLEADING CONTENT
[SALAH] Vaksin Covid-19 Jadi Penyebab Kematian Pelari dan Pendaki
mengunggah narasi [arsip] sebagai berikut: Lagi-lagi ada kasus serangan jantung sehingga pingsan dan MD. Kali ini akibat kelelahan mendaki gunung 😢 mohon jika sudah vaksin covid

Penjelasan
Faktanya Anggota Komite Nasional Kejadian Ikutan Pasca Imunisasi (Komnas KIPI), Dr. Arif Nur Muhammad Ansori, mengatakan efek samping vaksin Covid-19 memang pernah dilaporkan, seperti miokarditis pada vaksin mRNA dan gangguan pembekuan darah pada vaksin vektor adenovirus. Namun, efek tersebut umumnya muncul beberapa hari setelah vaksinasi, bukan bertahun-tahun kemudian. Klaim bahwa kematian pelari dan pendaki disebabkan vaksin tidak dapat dibenarkan tanpa pemeriksaan medis.

Menurut Arif, kematian saat berolahraga dapat dipicu berbagai faktor, seperti penyakit jantung yang belum terdiagnosis, dehidrasi, heat stroke, gangguan elektrolit, atau kelelahan berat. Sementara pada pendaki, kondisi seperti kekurangan oksigen dan cuaca ekstrem juga dapat menjadi penyebab. Ia menegaskan bahwa orang yang telah pulih dari efek samping ringan vaksin tetap dapat beraktivitas dan berolahraga seperti biasa. Guru Besar Fakultas Kedokteran UGM, Prof. Dr. dr. Denny Agustiningsih, menyampaikan penelitian menunjukkan aktivitas fisik tetap aman dilakukan setelah vaksinasi dan bahkan dapat membantu meningkatkan respons antibodi. Ia menambahkan, kematian saat berolahraga umumnya berkaitan dengan gangguan jantung,

Kesimpulan
Para ahli menjelaskan efek samping serius vaksin sangat jarang terjadi, umumnya muncul dalam beberapa hari setelah vaksinasi. Adapun penyebab kematian saat berolahraga atau mendaki harus dipastikan melalui pemeriksaan medis. Jadi, unggahan berisi klaim “vaksin covid-19 jadi penyebab kematian pelari dan pendaki” merupakan konten yang menyesatkan (misleading content).

Link Referensi : https://t.co/Eua6O1AVgG

[Arif Nur Muhammad Ansori @arifnma]

A lighthearted exploration of #Eid al-Fitr as a catalyst for well-being, #family connections, and statistically significant increases in food intake (p<0.001). Because #science must investigate everything, including rendang and opor ayam.
#EidMubarak 1447 H, everyone! ❤️

[IRCMS, Kumamoto University @IRCMS_KU]

🎉 Happy Birthday, #Kumamon! 🎂

Thanks to him, people all over the world have come to know about Kumamoto Prefecture. Whether you're into travel or study, Kumamoto is a fantastic place to visit — and we wouldlove to welcome you here! 🐻✨

#くまモン #Kumamoto #HappyBirthday

[Arif Nur Muhammad Ansori @arifnma]

#ViBioM2026, organized by the @EVirusBioinfC. The meeting will take place in Vilnius, Lithuania, in May 2026. This year, I am representing @Unair_Official as a member of the Scientific Committee, contributing to the academic direction and program development of the conference.

[Viruses MDPI @VirusesMDPI]

Despite shared #retroviral features, HTLV-1 and HIV-1 employ distinct transcriptional strategies, a distinction examined in this comparative review with implications for divergent outcomes in #viral persistence and disease.

👉Read the full paper: https://t.co/kux1qEKykW

[Arli AP @arli_ap]

I just received my edited book contribution, co-edited with Dr @arifnma and Dr Adhit 😊.
Explore the cutting-edge world of CRISPR technologies! #Biotechnology #i3l #biomedicine #i3luniversity
The link to our contribution is here:
https://t.co/X6PXCs5x8i

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Prof. Satou (@Sato_Y_Lab, @KumamotoUniv_PR) will present pioneering research on silencer mechanisms and advanced studies of HTLV-1 infection, contributing to this global dialogue on understanding and combating infectious diseases. 🦠🌍
>>> https://t.co/JzwUMInoDo
#Kumamoto #Japan

[Satou Lab - Hokkaido University @Sato_Y_Lab]

We’re proud to share that Prof. Yorifumi Satou will speak at the Viruses Webinar | 2025 The World HTLV Day (@MDPIOpenAccess @VirusesMDPI).
Talk: "HTLV-1 Persistence: A Virological Perspective"
Nov 5, 2025 | 18:35–19:05 JST
🔗https://t.co/nF20auug6H #WorldHTLVDay #HTLV1 #MDPI

[Satou Lab - Hokkaido University @Sato_Y_Lab]

We’re proud to share that Prof. Yorifumi Satou will speak at the Viruses Webinar | 2025 The World HTLV Day (@MDPIOpenAccess @VirusesMDPI).
Talk: “HTLV-1 Persistence: A Virological Perspective”
Nov 5, 2025 | 18:35–19:05 JST
🔗 https://t.co/nF20auuNWf
#WorldHTLVDay #HTLV1 #MDPI

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Our lab member, @arifnma, represented us at the 27th Summer #Retrovirus Conference (#SRC2025) in #Tsukuba, #Japan, where he presented his preliminary work on BLV Cell-Free DNA as a biomarker for EBL, highlighting novel non-invasive approaches in veterinary #virology.

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Our research, "Circulating Cell‐Free DNA of Bovine Leukemia Virus: A Promising Biomarker for Enzootic Bovine Leukosis", has been published!
Read it here: https://t.co/yWotEDiy2H
Don’t forget to follow us!
Let’s connect and collaborate!
#publishedarticle @wileyinresearch

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Among many outstanding sessions, Prof. Satou’s talk on “Circulating Cell-Free DNA of Bovine Leukemia Virus: A Promising Biomarker for Enzootic Bovine Leukosis (EBL)” stood out as the only presentation combining cutting-edge cfDNA technology with EBL detection.
🧬🐄

[Arif Nur Muhammad Ansori @arifnma]

I’m serving as Lead Editor for @FrontiersIn Virology (Research Topic) on “Bridging Gaps in Antiviral Therapy: Innovative Approaches in Drug Discovery and Vaccine Development”. Submissions are open! 🔬
https://t.co/rvwMrZ3163

[SciProfiles MDPI @SciProfiles]

🎉 Meet Dr. Arif Nur Muhammad Ansori ( @arifnma ), Researcher & Director of VRCBB 🇮🇩, who’s driving global health innovation.

🧪 His latest study finds plasma cfDNA of BLV is a precise biomarker for EBL diagnosis.

🌐 Connect now: https://t.co/hBoi9Ueoab

#AcademicTwitter

[IRCMS, Kumamoto University @IRCMS_KU]

📢 Open for entries / AY2025 IRCMS Research Internship program

⏰August 22, 2025

Apply here👉https://t.co/FxBESKDf7Q

#IRCMS #internship #kumamotouniversity #インターンシップ #熊本大学 #修士 #博士 @TakizawaLab

[Arif Nur Muhammad Ansori @arifnma]

Honored to have represented @Sato_Y_Lab at #SRC2025 in Tsukuba, Japan, sharing my preliminary research on Bovine Leukemia Virus Cell-Free DNA as a biomarker for Enzootic Bovine Leukosis. 🦠🧬🐮

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Our lab member, @arifnma, represented us at the 27th Summer #Retrovirus Conference (#SRC2025) in #Tsukuba, #Japan, where he presented his preliminary work on BLV Cell-Free DNA as a biomarker for EBL, highlighting novel non-invasive approaches in veterinary #virology.

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Big congratulations to Ms. Ishrat Jahan on successfully defending her PhD this afternoon! 🎓👏🔥
Her dissertation has also been published in Microbiology and Immunology (@WileyGlobal)! 🧬🐄
📖 https://t.co/yWotEDiy2H

[Masahiro Ono @ Tocky Lab @MonoTockyLab]

🚀Thrilled to announce our new Tocky-CRISPR-Deep Learning paper!
✅ConvNet + Grad-CAM decodes fluorescent timer (Tocky) data
✅Enables single-cell identification of enhancer-dependent Foxp3 transcription dynamics
https://t.co/YAQepboYJs
🔥A step toward data-driven immunology!

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Last month, our principal investigator, Professor Yorifumi Satou, was honored to deliver a distinguished international guest lecture at the 19th Biennial Scientific #Conference of the Australian Centre for HIV & Hepatitis #Virology Research (ACH4) in #Sydney, #Australia. 🇯🇵🇦🇺

[Satou Lab - Hokkaido University @Sato_Y_Lab]

Dr. @masahirono (@imperialcollege, UK), together with Dr. Nobuko Irie, Dr. Naoki Takeda, @Sato_Y_Lab, and Prof. Kimi Araki, has unveiled a machine learning-powered method to decode transcriptional dynamics using a Fluorescent Timer system.
@NatureComms, https://t.co/PL68uYCLUx